{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-091744","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2022-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.586603+00:00","generated_at":"2026-06-23T23:25:08.408205+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"SELLAS Life Sciences elects Katherine Bach Kalin to its Board of Directors","bullets":["Elected on Aug 13, 2022 as Class II director, term until 2024 annual meeting.","Granted option for 19,000 shares at $3.10/share, vesting one year from grant.","Over 25 years life sciences experience; led corporate strategy at Celgene 2012-2017.","Also on boards of Genfit (GNFT), Brown Advisory, and FemHealth Ventures.","Board determined she is independent under SEC and Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-091744","json":"https://secwatch.observer/filing/0001104659-22-091744.json","markdown":"https://secwatch.observer/filing/0001104659-22-091744.md","text":"https://secwatch.observer/filing/0001104659-22-091744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922091744/0001104659-22-091744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922091744/tm2223534d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T23:25:08.408205+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16a48dc310","claim":"Katherine Bach Kalin was elected as Director at SELLAS Life Sciences Group, Inc..","evidence_excerpt":"On August 13, 2022, the Board of Directors (the “Board”) of SELLAS Life Sciences Group, Inc. (the “Company”) elected Katherine Bach Kalin as a member of the Board, effective immediately, to serve as a Class II director until the Company’s 2024 annual meeting of stockholders and thereafter until her successor is duly elected and qualified or until her earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1390478/000110465922091744/0001104659-22-091744-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}